MedPath

KEYTRUDA 50 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION

KEYTRUDA 50 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION

Pending
Register Number

115024001IP

Prescription Type

Uso Hospitalario

Authorization Date

Oct 10, 2019

Dosage Form

POLVO PARA CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN

Route: VÍA INTRAVENOSA

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number115024001IP
EMA Approved
Yes

Drug Classification

Generic
No
Orphan
No
Biosimilar
No
Commercialized
No
CIMA AEMPS Classification

INGREDIENTS (1)

PEMBROLIZUMABActive
Quantity: 50,0 mg
Name: PEMBROLIZUMAB

ATC CLASSIFICATION (3)

L01F
L01FF
L01FF02

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.